{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:04:51Z","timestamp":1794013491523,"version":"4.8.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1053\/j.semnuclmed.2025.06.001","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T20:42:27Z","timestamp":1749674547000},"page":"503-511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Current Developments on [18F]FDG PET\/CT in Inflammatory Disorders of the Central Nervous System"],"prefix":"10.1053","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1370-8791","authenticated-orcid":false,"given":"Gilles N.","family":"Stormezand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Doorduin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8081-0641","authenticated-orcid":false,"given":"Andor W.J.M.","family":"Glaudemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anouk","family":"van der Hoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bauke M.","family":"De Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0001","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2967\/jnumed.112.112524","article-title":"EANM\/SNMMI guideline for 18F-FDG use in inflammation and infection","volume":"54","author":"Jamar","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.comppsych.2024.152480","article-title":"Role of F-18 FDG PET-CT in neuropsychiatric systemic lupus erythematosus","volume":"132","author":"Berndorfler","year":"2024","journal-title":"Compr Psychiatry"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0003","doi-asserted-by":"crossref","first-page":"eabe5640","DOI":"10.1126\/scitranslmed.abe5640","article-title":"Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases","volume":"13","author":"Xiang","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0004","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S1474-4422(23)00083-2","article-title":"Diagnostic criteria for autoimmune encephalitis: utility and pitfalls for antibody-negative disease","volume":"22","author":"Dalmau","year":"2023","journal-title":"Lancet Neurol"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0005","doi-asserted-by":"crossref","first-page":"155","DOI":"10.7861\/clinmedicine.18-2-155","article-title":"Acute encephalitis - diagnosis and management","volume":"18","author":"Ellul","year":"2018","journal-title":"Clin Med (Lond)"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0006","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0007","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/jnnp-2020-325300","article-title":"Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management","volume":"92","author":"Abboud","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0008","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/brain\/awh077","article-title":"Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis","volume":"127","author":"Vincent","year":"2004","journal-title":"Brain"},{"issue":"Pt 2","key":"10.1053\/j.semnuclmed.2025.06.001_bib0009","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/brain\/113.2.291","article-title":"Acute disseminated encephalomyelitis. MRI findings and the distinction from multiple sclerosis","volume":"113","author":"Kesselring","year":"1990","journal-title":"Brain"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0010","doi-asserted-by":"crossref","first-page":"e352","DOI":"10.1212\/NXI.0000000000000352","article-title":"Abnormal brain metabolism on FDG-PET\/CT is a common early finding in autoimmune encephalitis","volume":"4","author":"Probasco","year":"2017","journal-title":"Neurol(R) Neuroimmunol Neuroinflammat"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0011","doi-asserted-by":"crossref","first-page":"e3534","DOI":"10.1002\/brb3.3534","article-title":"Antibody-positive autoimmune encephalitis and paraneoplastic neurological syndrome: a Swedish case series","volume":"14","author":"Kosek","year":"2024","journal-title":"Brain Behav"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0012","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1007\/s00415-013-7048-2","article-title":"Cerebral FDG-PET and MRI findings in autoimmune limbic encephalitis: correlation with autoantibody types","volume":"260","author":"Baumgartner","year":"2013","journal-title":"J Neurol"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0013","doi-asserted-by":"crossref","first-page":"E516","DOI":"10.1097\/RLU.0000000000004862","article-title":"Diagnostic superiority of 18F-FDG PET over MRI in detecting anti-LGI1 autoimmune encephalitis: a comparative study with insights into faciobrachial dystonic seizures mechanisms and recurrence identification","volume":"48","author":"Liang","year":"2023","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0014","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/RLU.0000000000005574","article-title":"Regional metabolic abnormalities in autoimmune encephalitis: a meta-analysis of 498 cases with brain FDG PET","volume":"50","author":"Kosek","year":"2024","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577598","article-title":"Epidemiology of neuronal surface antibody-mediated autoimmune encephalitis and antibody-based diagnostics","volume":"357","author":"Zuliani","year":"2021","journal-title":"J Neuroimmunol"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2023.120830","article-title":"Autoimmune and paraneoplastic neurological disorders: a review of relevant neuroimaging findings","volume":"454","author":"Akkus","year":"2023","journal-title":"J Neurol Sci"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0017","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11912-018-0721-y","article-title":"Updates in the diagnosis and treatment of paraneoplastic neurologic syndromes","volume":"20","author":"Grativvol","year":"2018","journal-title":"Curr Oncol Rep"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0018","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.mayocp.2020.01.032","article-title":"Whole-body 18F-FDG PET-CT in the diagnosis of neurosarcoidosis","volume":"95","author":"Fritz","year":"2020","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0019","doi-asserted-by":"crossref","DOI":"10.1186\/s42466-023-00299-9","article-title":"Reevaluating the relevance of 18F-FDG PET findings for diagnosis of neurosarcoidosis: a case series","volume":"6","author":"Chen","year":"2024","journal-title":"Neurolog Res Practice"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0020","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1016\/S1473-3099(21)00703-9","article-title":"A clinical case definition of post-COVID-19 condition by a Delphi consensus","volume":"22","author":"Soriano","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101044","article-title":"Cognitive deficits in people who have recovered from COVID-19","volume":"39","author":"Hampshire","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0022","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/fampra\/cmab076","article-title":"Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review","volume":"39","author":"van Kessel","year":"2022","journal-title":"Fam Pract"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0023","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1007\/s00259-021-05215-4","article-title":"(18)F-FDG brain PET hypometabolism in patients with long COVID","volume":"48","author":"Guedj","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0024","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1007\/s00259-024-06937-x","article-title":"Persistent dysfunctions of brain metabolic connectivity in long-covid with cognitive symptoms","volume":"52","author":"Martini","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0025","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s00259-022-05942-2","article-title":"Time-dependent recovery of brain hypometabolism in neuro-COVID-19 patients","volume":"50","author":"Martini","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0026","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1007\/s00259-022-06013-2","article-title":"Brain (18)F-FDG PET imaging in outpatients with post-COVID-19 conditions: findings and associations with clinical characteristics","volume":"50","author":"Goehringer","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0027","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1097\/RLU.0000000000005614","article-title":"Cognitive impairment and brain metabolic changes in post-acute sequelae of COVID-19: insights from an [18 F]FDG PET\/CT cohort study","volume":"50","author":"Rozenblum","year":"2024","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0028","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1007\/s00259-024-06775-x","article-title":"Persistent brain metabolic impairment in long COVID patients with persistent clinical symptoms: a nine-month follow-up [(18)F]FDG-PET study","volume":"51","author":"Horowitz","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0029","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1007\/s00259-022-05753-5","article-title":"Visual interpretation of brain hypometabolism related to neurological long COVID: a French multicentric experience","volume":"49","author":"Verger","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0030","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1007\/s00259-022-05913-7","article-title":"2-[18F]-FDG PET for imaging brain involvement in patients with long COVID: perspective of the EANM Neuroimaging Committee","volume":"49","author":"Verger","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0031","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.radcr.2022.01.002","article-title":"Striatal dominant lupus encephalitis-is it vasculitis or an autoimmune process? Literature review & new case report with vessel wall imaging","volume":"17","author":"Raventhiranathan","year":"2022","journal-title":"Radiol Case Rep"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0032","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000008049","article-title":"Regional specific changes of cerebral metabolism in systemic lupus erythematosus identified by positron emission tomography","volume":"41","author":"de Jong","year":"1999","journal-title":"Eur Neurol"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0033","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/RLU.0b013e318192c435","article-title":"Hypermetabolism in bilateral basal ganglia in Sydenham chorea on F-18 FDG PET-CT","volume":"34","author":"Ho","year":"2009","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0034","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1007\/s00259-023-06110-w","article-title":"[(18)F]FDG PET in conditions associated with hyperkinetic movement disorders and ataxia: a systematic review","volume":"50","author":"Timmers","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0035","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1002\/art.30458","article-title":"Neuroimaging evidence of white matter inflammation in newly diagnosed systemic lupus erythematosus","volume":"63","author":"Ramage","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0036","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0140-6736(03)14366-8","article-title":"Whole-body positron emission tomography in patients with HIV-1 infection","volume":"362","author":"Scharko","year":"2003","journal-title":"Lancet"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0037","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/00004728-199507000-00004","article-title":"Differential diagnosis of CNS lesions in AIDS patients by FDG-PET","volume":"19","author":"Villringer","year":"1995","journal-title":"J Comput Assist Tomogr"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0038","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2214\/AJR.19.22629","article-title":"Imaging in differentiating cerebral toxoplasmosis and primary CNS lymphoma with special focus on FDG PET\/CT","volume":"216","author":"Marcus","year":"2020","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"10.1053\/j.semnuclmed.2025.06.001_bib0039","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3390\/ijms18040785","article-title":"Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases","volume":"18","author":"Dupont","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1053\/j.semnuclmed.2025.06.001_bib0040","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-072611","article-title":"Neurobiological basis and risk factors of persistent fatigue and concentration problems after COVID-19: study protocol for a prospective case-control study (VeCosCO)","volume":"13","author":"Verveen","year":"2023","journal-title":"BMJ Open"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0041","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1007\/s00259-023-06190-8","article-title":"Characterization of neuroinflammation pattern in anti-LGI1 encephalitis based on TSPO PET and symptom clustering analysis","volume":"50","author":"Wang","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0042","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.230397","article-title":"Microglial activation imaging using (18)F-DPA-714 PET\/MRI for detecting autoimmune encephalitis","volume":"310","author":"Zhang","year":"2024","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0043","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.2967\/jnumed.116.184333","article-title":"Diagnostic value of (18)F-FDG PET\/CT versus MRI in the setting of antibody-specific autoimmune encephalitis","volume":"58","author":"Solnes","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0044","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S1474-4422(16)30140-5","article-title":"Role of 18F-FDG-PET imaging in the diagnosis of autoimmune encephalitis","volume":"15","author":"Morbelli","year":"2016","journal-title":"Lancet Neuro"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0045","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00259-016-3589-9","article-title":"The need of standardization and of large clinical studies in an emerging indication of [18F]FDG PET: the autoimmune encephalitis","volume":"44","author":"Morbelli","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0046","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/00003072-200410000-00004","article-title":"FDG-PET findings in patients with suspected encephalitis","volume":"29","author":"Lee","year":"2004","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0047","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neuroscience.2015.05.037","article-title":"Imaging of autoimmune encephalitis\u2013relevance for clinical practice and hippocampal function","volume":"309","author":"Heine","year":"2015","journal-title":"Neuroscience"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0048","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1523\/JNEUROSCI.0167-10.2010","article-title":"Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis","volume":"30","author":"Hughes","year":"2010","journal-title":"J Neurosci"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0049","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/brain\/aws082","article-title":"Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis","volume":"135","author":"Bien","year":"2012","journal-title":"Brain"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0050","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2214\/AJR.20.23336","article-title":"The role of SPECT and PET in epilepsy","volume":"216","author":"Ponisio","year":"2021","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0051","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/RLU.0000000000000676","article-title":"(18)F-FDG PET\/CT and MRI findings in a patient with anti-GABA(B) receptor encephalitis","volume":"40","author":"Su","year":"2015","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0052","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jneuroim.2014.04.002","article-title":"Serial brain (1)(8)FDG-PET in anti-AMPA receptor limbic encephalitis","volume":"271","author":"Spatola","year":"2014","journal-title":"J Neuroimmunol"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0053","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/RLU.0000000000001164","article-title":"Changing brain metabolism patterns in patients with ANMDARE: serial 18F-FDG PET\/CT findings","volume":"41","author":"Yuan","year":"2016","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2025.06.001_bib0054","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13613-025-01444-0","article-title":"[(18)F]FDG PET\/CT identifies infectious and inflammatory foci in persistent critical illness","volume":"15","author":"van Leer","year":"2025","journal-title":"Ann Intensive Care"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299825000662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299825000662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T17:08:33Z","timestamp":1751476113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299825000662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0001299825000662"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2025.06.001","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current Developments on [18F]FDG PET\/CT in Inflammatory Disorders of the Central Nervous System","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2025.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}